FK 506SEWING, K.-F; CHRISTIANS, U.Lancet (British edition). 1991, Vol 337, Num 8739, issn 0140-6736, p. 499Article

Effect of FK-506, a novel immunosuppressive drug on murine systemic lupus erythematosusTAKABAYASHI, K; KOIKE, T; KURASAWA, K et al.Clinical immunology and immunopathology (Print). 1989, Vol 51, Num 1, pp 110-117, issn 0090-1229, 8 p.Article

Cyclosporin A inhibits the replication of diverse coronavirusesDE WILDE, Adriaan H; ZEVENHOVEN-DOBBE, Jessika C; VAN DER MEER, Yvonne et al.Journal of general virology. 2011, Vol 92, pp 2542-2548, issn 0022-1317, 7 p., 11Article

Inhibition of the immune response to alloantigen in the rat by exposure to ultraviolet radiationMAGEE, M. J; KRIPKE, M. L; ULLRICH, S. E et al.Photochemistry and photobiology. 1989, Vol 50, Num 2, pp 193-199, issn 0031-8655, 7 p.Article

Evidence that cyclosporine-incubated platelets retain function and release cyclosporineSHARPE, R. J; SCHWEIZER, R. T; MOORE, R. E et al.Transplantation. 1985, Vol 40, Num 1, pp 102-104, issn 0041-1337Article

Le tacrolimus (FK 506) = Tracolimus (FK 506)MEUNIER, B; MORDELET, M. F; LEBERT, C et al.Journal de pharmacie clinique (Paris). 1996, Vol 15, Num 2, pp 99-105, issn 0291-1981Conference Paper

Tacrolimus : a new immunosuppressive agentKELLY, P. A; BURCKART, G. J; RAMAN VENKATARAMANAN et al.American journal of health-system pharmacy. 1995, Vol 52, Num 14, pp 1521-1535, issn 1079-2082Article

Proceedings/International conference on the pharmacology of cyclosporine, Hardangervidda, Norway, July 31-August 3, 1986KAHAN, B. D.Transplantation proceedings. 1986, Vol 18, Num 6, issn 0041-1345, 273 p., suppl. 5Conference Proceedings

Surveillance des patients sous immunosuppresseursBILLIAUWS, Lore; PARIENTE, Benjamin.La Revue du praticien. Médecine générale. 2014, Num 917, pp 193-194, issn 0989-2737, 2 p.Article

The use of cyclosporine in dermatology: Part IIRYAN, Caitriona; AMOR, Karrie T; MENTER, Alan et al.Journal of the American Academy of Dermatology. 2010, Vol 63, Num 6, pp 949-972, issn 0190-9622, 24 p.Article

Use of cyclosporin in psoriasisBOS, J. D; MEINARDI, M. M. H. M; VAN JOOST, T et al.Lancet (British edition). 1989, Num 8678/8679, pp 1500-1502, issn 0140-6736Article

The use of cyclosporine in dermatology: Part IAMOR, Karrie T; RYAN, Caitriona; MENTER, Alan et al.Journal of the American Academy of Dermatology. 2010, Vol 63, Num 6, pp 925-946, issn 0190-9622, 22 p.Article

Sesquiterpenes as ImmunosuppressantsMUNOZ-SUANO, Alba; CHINCHILLA, David; AGUILAR, Susana et al.Transplantation. 2009, Vol 88, Num 3, issn 0041-1337, S24-S30, SUPConference Paper

Ciclosporine-sandimmun = Ciclosporin-SandimmunBARDEY, V; CONSTANT, H; LEBOUCHER, G et al.Lyon pharmaceutique. 1994, Vol 45, Num 2, pp 113-115, issn 0024-7804Article

Molecular mechanics calculations of cyclosporin A analogues: effect of chirality and degree of substitution on the side-chain conformations of (2S,3R,4R,6E)-3-hydroxy-4-methyl-2-(methylamino)-6-octenoic acid and related derivativesMILLER, K. E; RICH, D. H.Journal of the American Chemical Society. 1989, Vol 111, Num 22, pp 8351-8362, issn 0002-7863, 12 p.Article

La ciclosporine topique: Quand et comment l'utiliser ?MILAZZO, Solange; DRIMBEA, Andrei; JANY, Benjamin et al.Pratiques en ophtalmologie. 2014, Vol 8, Num 76, pp 166-169, issn 2106-9735, 4 p.Article

Immunosuppressive Biological Mechanisms Support Reassessment of Use of the Injectable Contraceptive Medroxyprogesterone AcetateHAPGOOD, Janet P.Endocrinology (Philadelphia). 2013, Vol 154, Num 3, pp 985-988, issn 0013-7227, 4 p.Article

Mycophenolate Mofetil in Minimal Change NephrosisALFRED, R; SOYIBO, A. K.West indian medical journal. 2010, Vol 59, Num 3, pp 330-331, issn 0043-3144, 2 p.Article

Mycophenolate mofetil in dermatologyORVIS, Alissa K; WESSON, Stanton K; BREZA, Thomas S et al.Journal of the American Academy of Dermatology. 2009, Vol 60, Num 2, pp 183-199, issn 0190-9622, 17 p.Article

Overcoming immunosuppressive mechanismsWIDEN, K; MOZAFFARI, F; CHOUDHURY, A et al.Annals of oncology. 2008, Vol 19, issn 0923-7534, vii241-vii247, SUP7Article

Les traitements immunosuppresseurs systémiques en dermatologieRICHEZ, P; MAROT, L; LACHAPELLE, J. M et al.Louvain médical. 2005, Vol 124, Num 6, pp S135-S144, issn 0024-6956Article

ESOT update on immunosuppressive substances in clinical development or use 1995THIEL, G.Transplant international. 1996, Vol 9, Num 3, pp 171-174, issn 0934-0874Article

Tacrolimus, a new immunosuppressant : a review of the literatureHOOKS, M. A.The Annals of pharmacotherapy. 1994, Vol 28, Num 4, pp 501-511, issn 1060-0280Article

Clinical utility of cyclosporine concentrations determined in recipiens of small-bowel transplant by HPLC and fluorescence polarization immunoassaySADEG, N; PHAM HUY, C; POSTAIRE, M et al.Clinical chemistry (Baltimore, Md.). 1991, Vol 37, Num 2, issn 0009-9147, p. 291Article

Isolation of Bacillus stearothermophilus constituent that suppresses mouse mixed leukocyte reaction in vitroKOHAMA, Y; MURAYAMA, N; TANAKA, K et al.Chemical and pharmaceutical bulletin. 1991, Vol 39, Num 12, pp 3378-3380, issn 0009-2363Article